This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2011-09-27 RCRIM Call Agenda"

From HL7Wiki
Jump to navigation Jump to search
(Created page with "Category:RCRIM Agendas Return to RCRIM Teleconference Minutes and Agendas ===Meeting Information=== {|border="1" cellpadding="2" cellspacing="0" | width="50%" colspan=...")
 
Line 40: Line 40:
 
#Agenda review and approval
 
#Agenda review and approval
 
#Approve meeting minutes from [[2011-08-30_RCRIM_Call_Minutes]]
 
#Approve meeting minutes from [[2011-08-30_RCRIM_Call_Minutes]]
#Action items from WGM
+
#Address comments on three year plan (if needed)
 +
#Project Scope Statement for Subject Data CDA IG
 +
#Approval of request to withdraw Subject Data
 +
#Discuss actions for current Study Design Ballot
 +
#Discuss timeing on Withdrawal of Study Design and Study Participation DAM
 
#Other Items
 
#Other Items
  

Revision as of 20:08, 20 September 2011


Return to RCRIM Teleconference Minutes and Agendas

Meeting Information

HL7 RCRIM Agenda

Location: Dial: 770-657-9270 Passcode: 745896#

Webex Info:

  1. Go to https://estripp.webex.com/estripp/j.php?ED=129183437&UID=0&PW=NNzQ1Nzg4NGZj&RT=MiM3
  2. If requested, enter your name and email address.
  3. If a password is required, enter the meeting password: RCRIM
Date: 2011-09-27
Time: 10:00-11:00 am Eastern Time
Facilitator Ed Tripp Note taker(s) Ed Tripp
Attendee Name Affiliation
. . .
Quorum Requirements Met: (yes/No)
quorum for RCRIM is 10 plus a co-chair

Agenda

Agenda Topics

  1. Agenda review and approval
  2. Approve meeting minutes from 2011-08-30_RCRIM_Call_Minutes
  3. Address comments on three year plan (if needed)
  4. Project Scope Statement for Subject Data CDA IG
  5. Approval of request to withdraw Subject Data
  6. Discuss actions for current Study Design Ballot
  7. Discuss timeing on Withdrawal of Study Design and Study Participation DAM
  8. Other Items


Supporting Documents
None

© 2010 Health Level Seven® International. All rights reserved.